TreeWAS – Variant ID: rs11260603

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N08.3 Glomerular disorders in diabetes mellitus	0.044	0.956	0.000
Z13.9 Special screening examination, unspecified	0.041	0.959	0.000
Y57.9 Drug or medicament, unspecified	0.038	0.962	0.000
Y57 Other and unspecified drugs and medicaments	0.031	0.969	0.000
Y57.5 X-ray contrast media	0.027	0.973	0.000
Z72.0 Tobacco use	0.026	0.974	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.026	0.974	0.000
Y52 Agents primarily affecting the cardiovascular system	0.026	0.974	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.025	0.975	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.025	0.975	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.025	0.975	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.024	0.976	0.000
Y57.6 Other diagnostic agents	0.024	0.976	0.000
Y57.7 Vitamins, not elsewhere classified	0.022	0.977	0.000
Y57.4 Pharmaceutical excipients	0.022	0.977	0.000
Y57.3 Alcohol deterrents	0.022	0.977	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.022	0.977	0.000
Y57.1 Lipotropic drugs	0.022	0.977	0.000
Y57.0 Appetite depressants [anorectics]	0.022	0.977	0.000
Y42.7 Androgens and anabolic congeners	0.022	0.978	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.022	0.978	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.021	0.979	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.021	0.979	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.021	0.979	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.021	0.979	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.020	0.980	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.020	0.980	0.000
Y58 Bacterial vaccines	0.020	0.980	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.020	0.980	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.019	0.981	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.019	0.981	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.019	0.981	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.019	0.981	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.019	0.981	0.000
Y42.4 Oral contraceptives	0.019	0.981	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.019	0.981	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.019	0.981	0.000
Y52.7 Peripheral vasodilators	0.019	0.981	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.018	0.981	0.000
Y42.5 Other oestrogens and progestogens	0.018	0.982	0.000
Y46.4 Iminostilbenes	0.018	0.982	0.000
Y42.9 Other and unspecified hormone antagonists	0.018	0.982	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.018	0.982	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.018	0.982	0.000
Y43 Primarily systemic agents	0.018	0.982	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.018	0.982	0.000
Y48 Anaesthetics and therapeutic gases	0.018	0.982	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.017	0.983	0.000
Y44 Agents primarily affecting blood constituents	0.017	0.983	0.000
Y57.8 Other drugs and medicaments	0.017	0.983	0.000
Y55.4 Expectorants	0.017	0.983	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.017	0.983	0.000
Y42.1 Thyroid hormones and substitutes	0.017	0.983	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.017	0.983	0.000
Y42.2 Antithyroid drugs	0.016	0.983	0.000
Y46.6 Other and unspecified antiepileptics	0.016	0.984	0.000
Y58.0 BCG vaccine	0.016	0.984	0.000
Y46.7 Anti-Parkinsonism drugs	0.016	0.984	0.000
Y59 Other and unspecified vaccines and biological substances	0.016	0.984	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.016	0.984	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.016	0.984	0.000
Y46.8 Antispasticity drugs	0.015	0.984	0.000
Y46.5 Valproic acid	0.015	0.984	0.000
Y46.3 Deoxybarbiturates	0.015	0.984	0.000
Y46.1 Oxazolidinediones	0.015	0.984	0.000
Y46.0 Succinimides	0.015	0.984	0.000
Y52.1 Calcium-channel blockers	0.015	0.985	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.015	0.985	0.000
Y41.4 Anthelminthics	0.015	0.985	0.000
Y41.3 Other antiprotozoal drugs	0.015	0.985	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.015	0.985	0.000
Y41.1 Antimycobacterial drugs	0.015	0.985	0.000
Y43.4 Immunosuppressive agents	0.015	0.985	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.015	0.985	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.015	0.985	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.015	0.985	0.000
Y55.5 Anticommon cold drugs	0.015	0.985	0.000
Y55.3 Antitussives	0.015	0.985	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.015	0.985	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.015	0.985	0.000
Y55.0 Oxytocic drugs	0.015	0.985	0.000
Y46.2 Hydantoin derivatives	0.015	0.985	0.000
Y41.0 Sulphonamides	0.014	0.985	0.000
Y58.9 Other and unspecified bacterial vaccines	0.014	0.985	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.014	0.985	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.014	0.985	0.000
Y58.5 Diphtheria vaccine	0.014	0.985	0.000
Y58.4 Tetanus vaccine	0.014	0.985	0.000
Y58.3 Plague vaccine	0.014	0.985	0.000
Y58.2 Cholera vaccine	0.014	0.985	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.014	0.985	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.014	0.986	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.014	0.986	0.000
Y48.4 Anaesthetic, unspecified	0.014	0.986	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.014	0.986	0.000
Y49.9 Psychotropic drug, unspecified	0.014	0.986	0.000
Y49.7 Psychostimulants with abuse potential	0.014	0.986	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.014	0.986	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.014	0.986	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.014	0.986	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.014	0.986	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.014	0.986	0.000
Y49.5 Other antipsychotics and neuroleptics	0.014	0.986	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.014	0.986	0.000
Y50.9 Central nervous system stimulant, unspecified	0.013	0.987	0.000
Y50.8 Other central nervous system stimulants	0.013	0.987	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.013	0.987	0.000
Y50.1 Opioid receptor antagonists	0.013	0.987	0.000
Y50.0 Analeptics	0.013	0.987	0.000
Y44.5 Thrombolytic drugs	0.013	0.987	0.000
Y43.9 Primarily systemic agent, unspecified	0.013	0.987	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.013	0.987	0.000
Y43.6 Enzymes, not elsewhere classified	0.013	0.987	0.000
Y43.5 Acidifying and alkalising agents	0.013	0.987	0.000
Y43.2 Antineoplastic natural products	0.013	0.987	0.000
Y48.5 Therapeutic gases	0.013	0.987	0.000
Y48.1 Parenteral anaesthetics	0.013	0.987	0.000
Y48.0 Inhaled anaesthetics	0.013	0.987	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.013	0.987	0.000
Y43.1 Antineoplastic antimetabolites	0.013	0.987	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.013	0.987	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.013	0.987	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.013	0.987	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.013	0.987	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.013	0.987	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.013	0.987	0.000
Y51.0 Anticholinesterase agents	0.013	0.987	0.000
Y41.5 Antiviral drugs	0.013	0.987	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.013	0.987	0.000
Y44.7 Plasma substitutes	0.013	0.987	0.000
Y44.6 Natural blood and blood products	0.013	0.987	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.013	0.987	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.012	0.988	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.012	0.988	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.012	0.988	0.000
Y47.4 Bromine compounds	0.012	0.988	0.000
Y47.3 Paraldehyde	0.012	0.988	0.000
Y47.2 Chloral derivatives	0.012	0.988	0.000
Y47.0 Barbiturates, not elsewhere classified	0.012	0.988	0.000
Y49.2 Other and unspecified antidepressants	0.012	0.988	0.000
Y43.0 Antiallergic and antiemetic drugs	0.012	0.988	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.012	0.988	0.000
Y56.9 Topical agent, unspecified	0.012	0.988	0.000
Y56.8 Other topical agents	0.012	0.988	0.000
Y56.7 Dental drugs, topically applied	0.012	0.988	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.012	0.988	0.000
Y56.5 Ophthalmological drugs and preparations	0.012	0.988	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.988	0.000
Y56.3 Emollients, demulcents and protectants	0.012	0.988	0.000
Y56.2 Local astringents and local detergents	0.012	0.988	0.000
Y56.1 Antipruritics	0.012	0.988	0.000
Y48.3 Local anaesthetics	0.012	0.988	0.000
Y48.2 Other and unspecified general anaesthetics	0.012	0.988	0.000
Y59.9 Vaccine or biological substance, unspecified	0.011	0.988	0.000
Y59.8 Other specified vaccines and biological substances	0.011	0.988	0.000
Y59.2 Protozoal vaccines	0.011	0.988	0.000
Y59.1 Rickettsial vaccines	0.011	0.988	0.000
Y59.0 Viral vaccines	0.011	0.988	0.000
Y47.1 Benzodiazepines	0.011	0.989	0.000
Y43.3 Other antineoplastic drugs	0.011	0.989	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.011	0.989	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.010	0.989	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.989	0.000
Y53.7 Emetics	0.010	0.989	0.000
Y53.6 Antidiarrhoeal drugs	0.010	0.989	0.000
Y53.5 Digestants	0.010	0.989	0.000
Y53.3 Saline and osmotic laxatives	0.010	0.989	0.000
Y53.2 Stimulant laxatives	0.010	0.989	0.000
Y53.0 Histamine H2-receptor antagonists	0.010	0.989	0.000
N00-N08 Glomerular diseases	0.010	0.990	0.000
K81.9 Cholecystitis, unspecified	0.000	0.990	0.010
Y59.3 Immunoglobulin	0.009	0.990	0.000
N02.8 Other	0.010	0.990	0.000
Y40 Systemic antibiotics	0.009	0.990	0.000
N04 Nephrotic syndrome	0.009	0.991	0.000
Y53.4 Other laxatives	0.009	0.991	0.000
N02 Recurrent and persistent haematuria	0.009	0.991	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.009	0.991	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.009	0.991	0.000
Z29.2 Other prophylactic chemotherapy	0.009	0.991	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.008	0.992	0.001
Y40.9 Systemic antibiotic, unspecified	0.008	0.992	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.008	0.992	0.000
Z92.6 Personal history of chemotherapy for neoplastic disease	0.008	0.992	0.000
N04.9 Unspecified	0.008	0.992	0.000
Y44.2 Anticoagulants	0.008	0.992	0.000
C81.9 Hodgkin's disease, unspecified	0.008	0.992	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.008	0.992	0.000
N06 Isolated proteinuria with specified morphological lesion	0.008	0.992	0.000
N01 Rapidly progressive nephritic syndrome	0.008	0.992	0.000
N00 Acute nephritic syndrome	0.008	0.992	0.000
N04.2 Diffuse membranous glomerulonephritis	0.007	0.993	0.000
Y40.7 Antifungal antibiotics, systemically used	0.007	0.993	0.000
Y40.6 Rifamycins	0.007	0.993	0.000
Y40.5 Aminoglycosides	0.007	0.993	0.000
Y40.4 Tetracyclines	0.007	0.993	0.000
Y40.2 Chloramphenicol group	0.007	0.993	0.000
N02.2 Diffuse membranous glomerulonephritis	0.007	0.993	0.000
Y54.4 Loop [high-ceiling] diuretics	0.007	0.993	0.000
N04.8 Other	0.007	0.993	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.007	0.993	0.000
N04.6 Dense deposit disease	0.007	0.993	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.007	0.993	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.007	0.993	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.007	0.993	0.000
N04.1 Focal and segmental glomerular lesions	0.007	0.993	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.007	0.993	0.000
N02.6 Dense deposit disease	0.007	0.993	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.007	0.993	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.007	0.993	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.007	0.993	0.000
N02.1 Focal and segmental glomerular lesions	0.007	0.993	0.000
N02.0 Minor glomerular abnormality	0.007	0.993	0.000
C81.1 Nodular sclerosis	0.007	0.993	0.000
N04.0 Minor glomerular abnormality	0.007	0.993	0.000
Y54.9 Mineral salts, not elsewhere classified	0.006	0.993	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.006	0.993	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.006	0.993	0.000
Y54.0 Mineralocorticoids	0.006	0.993	0.000
Y40.3 Macrolides	0.007	0.993	0.000
Z13.1 Special screening examination for diabetes mellitus	0.007	0.993	0.000
Y54.7 Agents affecting calcification	0.006	0.994	0.000
C81 Hodgkin's disease	0.006	0.994	0.000
Z13 Special screening examination for other diseases and disorders	0.006	0.994	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.006	0.994	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.006	0.994	0.000
N00.9 Unspecified	0.006	0.994	0.000
N00.8 Other	0.006	0.994	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.006	0.994	0.000
N00.6 Dense deposit disease	0.006	0.994	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.994	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.994	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.994	0.000
N00.2 Diffuse membranous glomerulonephritis	0.006	0.994	0.000
N00.1 Focal and segmental glomerular lesions	0.006	0.994	0.000
N00.0 Minor glomerular abnormality	0.006	0.994	0.000
N01.9 Unspecified	0.006	0.994	0.000
N01.8 Other	0.006	0.994	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.006	0.994	0.000
N01.6 Dense deposit disease	0.006	0.994	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.994	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.994	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.994	0.000
N01.2 Diffuse membranous glomerulonephritis	0.006	0.994	0.000
N01.1 Focal and segmental glomerular lesions	0.006	0.994	0.000
N01.0 Minor glomerular abnormality	0.006	0.994	0.000
N06.9 Unspecified	0.006	0.994	0.000
N06.8 Other	0.006	0.994	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.006	0.994	0.000
N06.6 Dense deposit disease	0.006	0.994	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.994	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.994	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.994	0.000
N06.2 Diffuse membranous glomerulonephritis	0.006	0.994	0.000
N06.1 Focal and segmental glomerular lesions	0.006	0.994	0.000
N06.0 Minor glomerular abnormality	0.006	0.994	0.000
N07.9 Unspecified	0.006	0.994	0.000
N07.8 Other	0.006	0.994	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.006	0.994	0.000
N07.6 Dense deposit disease	0.006	0.994	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.994	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.994	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.994	0.000
N07.2 Diffuse membranous glomerulonephritis	0.006	0.994	0.000
N07.1 Focal and segmental glomerular lesions	0.006	0.994	0.000
N07.0 Minor glomerular abnormality	0.006	0.994	0.000
Y54.3 Benzothiadiazine derivatives	0.005	0.994	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.000	0.994	0.006
E10.5 With peripheral circulatory complications	0.006	0.994	0.000
Y40.0 Penicillins	0.006	0.994	0.000
N03 Chronic nephritic syndrome	0.005	0.994	0.000
F43.1 Posttraumatic stress disorder	0.000	0.994	0.005
R16.1 Splenomegaly, not elsewhere classified	0.000	0.995	0.005
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.995	0.005
E10.6 With other specified complications	0.005	0.995	0.000
Y54.5 Other diuretics	0.005	0.995	0.000
E10.2 With renal complications	0.005	0.995	0.000
E10 Insulin-dependent diabetes mellitus	0.005	0.995	0.000
N42.8 Other specified disorders of prostate	0.005	0.995	0.000
Y54.8 Agents affecting uric acid metabolism	0.005	0.995	0.000
Z13.2 Special screening examination for nutritional disorders	0.005	0.995	0.000
Y40.8 Other systemic antibiotics	0.005	0.995	0.000
C81.0 Lymphocytic predominance	0.005	0.995	0.000
I67.8 Other specified cerebrovascular diseases	0.005	0.995	0.000
E10.4 With neurological complications	0.005	0.995	0.000
Z13.7 Special screening examination for congenital malformations, deformations and chromosomal abnormalities	0.005	0.995	0.000
C81.7 Other Hodgkin's disease	0.005	0.995	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.005	0.995	0.000
C81.3 Lymphocytic depletion	0.005	0.995	0.000
Z13.8 Special screening examination for other specified diseases and disorders	0.005	0.995	0.000
Z13.4 Special screening examination for certain developmental disorders in childhood	0.005	0.995	0.000
N60.0 Solitary cyst of breast	0.005	0.995	0.000
C77.3 Axillary and upper limb lymph nodes	0.005	0.995	0.000
Y45.4 Antirheumatics	0.004	0.995	0.000
C81.2 Mixed cellularity	0.004	0.996	0.000
G24.9 Dystonia, unspecified	0.000	0.996	0.004
E10.0 With coma	0.004	0.996	0.000
Z13.3 Special screening examination for mental and behavioural disorders	0.004	0.996	0.000
N05 Unspecified nephritic syndrome	0.004	0.996	0.000
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.000	0.996	0.004
Z72 Problems related to lifestyle	0.004	0.996	0.000
E10.3 With ophthalmic complications	0.004	0.996	0.000
N03.8 Other	0.004	0.996	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
N03.6 Dense deposit disease	0.004	0.996	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
N03.2 Diffuse membranous glomerulonephritis	0.004	0.996	0.000
N03.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
N03.0 Minor glomerular abnormality	0.004	0.996	0.000
H91.9 Hearing loss, unspecified	0.000	0.996	0.004
F43.2 Adjustment disorders	0.000	0.996	0.004
F43 Reaction to severe stress, and adjustment disorders	0.000	0.996	0.004
Z03.9 Observation for suspected disease or condition, unspecified	0.004	0.996	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.004	0.996	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
E11.2 With renal complications	0.004	0.996	0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
E10.7 With multiple complications	0.004	0.996	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.996	0.002
Y45.5 4-Aminophenol derivatives	0.004	0.996	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
E10.8 With unspecified complications	0.004	0.996	0.000
F43.0 Acute stress reaction	0.000	0.996	0.004
Z13.83 Encounter for screening for respiratory disorder NEC	0.004	0.996	0.000
Z13.82 Encounter for screening for musculoskeletal disorder	0.004	0.996	0.000
Z13.5 Special screening examination for eye and ear disorders	0.004	0.996	0.000
Y45.2 Propionic acid derivatives	0.004	0.996	0.000
G70.0 Myasthenia gravis	0.004	0.996	0.000
Z72.8 Other problems related to lifestyle	0.004	0.996	0.000
R73.0 Abnormal glucose tolerance test	0.000	0.996	0.004
Y45.8 Other analgesics and antipyretics	0.003	0.996	0.000
N05.2 Diffuse membranous glomerulonephritis	0.003	0.996	0.000
Y45.1 Salicylates	0.003	0.996	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.004	0.996	0.000
G63.2 Diabetic polyneuropathy	0.004	0.996	0.000
N05.8 Other	0.003	0.997	0.000
N05.6 Dense deposit disease	0.003	0.997	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N05.0 Minor glomerular abnormality	0.003	0.997	0.000
Z72.9 Problem related to lifestyle, unspecified	0.003	0.997	0.000
Z72.6 Gambling and betting	0.003	0.997	0.000
Z72.5 High-risk sexual behaviour	0.003	0.997	0.000
Z72.3 Lack of physical exercise	0.003	0.997	0.000
C77.2 Intra-abdominal lymph nodes	0.003	0.997	0.000
F43.8 Other reactions to severe stress	0.000	0.997	0.003
J06.9 Acute upper respiratory infection, unspecified	0.003	0.997	0.000
Z72.4 Inappropriate diet and eating habits	0.003	0.997	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
Z63.4 Disappearance and death of family member	0.000	0.997	0.003
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.003	0.997	0.000
H17.9 Corneal scar and opacity, unspecified	0.000	0.997	0.003
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.003	0.997	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.003	0.997	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
M66.24 Spontaneous rupture of extensor tendons (Hand)	0.000	0.997	0.003
F43.9 Reaction to severe stress, unspecified	0.000	0.997	0.003
G70 Myasthenia gravis and other myoneural disorders	0.003	0.997	0.000
D11.9 Major salivary gland, unspecified	0.000	0.997	0.003
N60.2 Fibroadenosis of breast	0.003	0.997	0.000
G24.5 Blepharospasm	0.000	0.997	0.003
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.003	0.997	0.000
F20.0 Paranoid schizophrenia	0.000	0.997	0.003
K59.3 Megacolon, not elsewhere classified	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.003	0.997	0.000
Z72.2 Drug use	0.003	0.997	0.000
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
C82.3 Follicular lymphoma grade IIIa	0.003	0.997	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.003	0.997	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.003	0.997	0.000
G70.9 Myoneural disorder, unspecified	0.003	0.997	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.003	0.997	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.997	0.003
E10-E14 Diabetes mellitus	0.003	0.997	0.000
G24 Dystonia	0.000	0.997	0.003
E11.6 With other specified complications	0.003	0.997	0.000
E14.3 With ophthalmic complications	0.003	0.997	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.000	0.997	0.002
M06.9 Rheumatoid arthritis, unspecified	0.003	0.997	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.003	0.997	0.000
N05.9 Unspecified	0.002	0.997	0.000
N60 Benign mammary dysplasia	0.003	0.997	0.000
M95.0 Acquired deformity of nose	0.003	0.997	0.000
J35.0 Chronic tonsillitis	0.000	0.997	0.003
H17 Corneal scars and opacities	0.000	0.997	0.002
Z29 Need for other prophylactic measures	0.003	0.997	0.000
G72.0 Drug-induced myopathy	0.002	0.997	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.003	0.997	0.000
K57.2 Diverticular disease of large intestine with perforation and abscess	0.003	0.997	0.000
N60.4 Mammary duct ectasia	0.002	0.997	0.000
E11 Non-insulin-dependent diabetes mellitus	0.003	0.997	0.000
H91 Other hearing loss	0.000	0.998	0.002
N05.1 Focal and segmental glomerular lesions	0.002	0.998	0.001
Z63 Other problems related to primary support group, including family circumstances	0.000	0.998	0.002
C77.4 Inguinal and lower limb lymph nodes	0.002	0.998	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.002	0.998	0.000
E14.2 Withrenal complications	0.002	0.998	0.000
G70.8 Other specified myoneural disorders	0.002	0.998	0.000
G70.2 Congenital and developmental myasthenia	0.002	0.998	0.000
G70.1 Toxic myoneural disorders	0.002	0.998	0.000
E14 Unspecified diabetes mellitus	0.002	0.998	0.000
H91.1 Presbycusis	0.000	0.998	0.002
Z63.8 Other specified problems related to primary support group	0.000	0.998	0.002
G11.9 Hereditary ataxia, unspecified	0.002	0.998	0.000
C77.0 Lymph nodes of head, face and neck	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.998	0.000
D06.9 Cervix, unspecified	0.002	0.998	0.000
H16 Keratitis	0.000	0.998	0.002
H16.2 Keratoconjunctivitis	0.000	0.998	0.002
A04.5 Campylobacter enteritis	0.002	0.998	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.000	0.998	0.002
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.000	0.998	0.002
O23.4 Unspecified infection of urinary tract in pregnancy	0.002	0.998	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.998	0.002
C82.2 Large cell, follicular	0.002	0.998	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.000	0.998	0.002
J32.0 Chronic maxillary sinusitis	0.002	0.998	0.000
E12 Malnutrition-related diabetes mellitus	0.002	0.998	0.000
E11.4 With neurological complications	0.002	0.998	0.000
G24.4 Idiopathic orofacial dystonia	0.000	0.998	0.002
G24.2 Idiopathic nonfamilial dystonia	0.000	0.998	0.002
G24.1 Idiopathic familial dystonia	0.000	0.998	0.002
G24.0 Drug-induced dystonia	0.000	0.998	0.002
H91.2 Sudden idiopathic hearing loss	0.000	0.998	0.002
I35.2 Aortic (valve) stenosis with insufficiency	0.002	0.998	0.000
G72 Other myopathies	0.002	0.998	0.000
J34.2 Deviated nasal septum	0.002	0.998	0.000
N83.1 Corpus luteum cyst	0.002	0.998	0.000
Z63.5 Disruption of family by separation and divorce	0.000	0.998	0.002
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
E14.4 With neurological complications	0.002	0.998	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.000	0.998	0.002
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.000	0.998	0.002
E11.3 With ophthalmic complications	0.002	0.998	0.000
H91.3 Deaf mutism, not elsewhere classified	0.000	0.998	0.002
N60.3 Fibrosclerosis of breast	0.002	0.998	0.000
R00.0 Tachycardia, unspecified	0.002	0.998	0.000
Z63.7 Other stressful life events affecting family and household	0.000	0.998	0.002
H16.9 Keratitis, unspecified	0.000	0.998	0.002
H17.1 Other central corneal opacity	0.000	0.998	0.002
H17.0 Adherent leukoma	0.000	0.998	0.002
N03.9 Unspecified	0.002	0.998	0.000
Z29.9 Prophylactic measure, unspecified	0.002	0.998	0.000
S52.50 Fracture of lower end of radius (closed)	0.000	0.998	0.002
C09.9 Tonsil, unspecified	0.002	0.998	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.000	0.998	0.002
G70-G73 Diseases of myoneural junction and muscle	0.002	0.998	0.000
E11.7 With multiple complications	0.002	0.998	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.000	0.998	0.002
H91.0 Ototoxic hearing loss	0.000	0.998	0.002
H21 Other disorders of iris and ciliary body	0.000	0.998	0.002
C71.1 Frontal lobe	0.002	0.998	0.000
G24.8 Other dystonia	0.000	0.998	0.002
Z63.9 Problem related to primary support group, unspecified	0.000	0.998	0.002
Z63.3 Absence of family member	0.000	0.998	0.002
Z63.2 Inadequate family support	0.000	0.998	0.002
Z63.1 Problems in relationship with parents and in-laws	0.000	0.998	0.002
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
G24.3 Spasmodic torticollis	0.000	0.998	0.002
G72.4 Inflammatory myopathy, not elsewhere classified	0.002	0.998	0.000
E14.7 With multiple complications	0.002	0.998	0.000
E14.0 With coma	0.002	0.998	0.000
Z63.0 Problems in relationship with spouse or partner	0.000	0.998	0.002
H16.8 Other keratitis	0.000	0.998	0.002
M87.9 Osteonecrosis, unspecified	0.002	0.998	0.000
Z29.1 Prophylactic immunotherapy	0.002	0.998	0.000
H17.8 Other corneal scars and opacities	0.000	0.998	0.002
H18.5 Hereditary corneal dystrophies	0.000	0.998	0.002
I70.2 Atherosclerosis of arteries of the extremities	0.002	0.998	0.000
N60.9 Benign mammary dysplasia, unspecified	0.002	0.998	0.000
E14.6 With other specified complications	0.002	0.998	0.000
E14.1 With ketoacidosis	0.002	0.998	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.000	0.998	0.002
H15 Disorders of sclera	0.000	0.998	0.002
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
F20.9 Schizophrenia, unspecified	0.000	0.998	0.002
H16.4 Corneal neovascularisation	0.000	0.998	0.002
H16.3 Interstitial and deep keratitis	0.000	0.998	0.002
E14.8 With unspecified complications	0.002	0.998	0.000
Z63.6 Dependent relative needing care at home	0.000	0.998	0.002
F20 Schizophrenia	0.000	0.998	0.002
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
H15.8 Other disorders of sclera	0.000	0.998	0.002
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.000	0.998	0.002
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.000	0.998	0.002
J20.9 Acute bronchitis, unspecified	0.002	0.998	0.000
E12.9 Without complications	0.002	0.998	0.000
E12.8 With unspecified complications	0.002	0.998	0.000
E12.7 With multiple complications	0.002	0.998	0.000
E12.6 With other specified complications	0.002	0.998	0.000
E12.5 With peripheral circulatory complications	0.002	0.998	0.000
E12.4 With neurological complications	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations